v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Series A Preferred Stock
Additional 
Paid-In 
Capital
Accumulated 
Deficit
Accumulated 
Other 
Comprehensive 
Income (Loss)
Balance at the beginning of the period (in shares) at Dec. 31, 2024   121,476,215 1,000,000,000      
Balance at the beginning of the period at Dec. 31, 2024 $ 1,151,172 $ 12 $ 0 $ 1,293,638 $ (106,989) $ (35,489)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (25,793)       (25,793)  
Share-based compensation expense 1,107     1,107    
Other comprehensive income (loss) 2,561         2,561
Balance at the end of the period (in shares) at Mar. 31, 2025   121,476,215 1,000,000,000      
Balance at the end of the period at Mar. 31, 2025 1,129,047 $ 12 $ 0 1,294,745 (132,782) (32,928)
Balance at the beginning of the period (in shares) at Dec. 31, 2024   121,476,215 1,000,000,000      
Balance at the beginning of the period at Dec. 31, 2024 1,151,172 $ 12 $ 0 1,293,638 (106,989) (35,489)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (26,026)          
Balance at the end of the period (in shares) at Jun. 30, 2025   121,476,215 1,000,000,000      
Balance at the end of the period at Jun. 30, 2025 1,179,063 $ 12 $ 0 1,296,618 (133,015) 15,448
Balance at the beginning of the period (in shares) at Mar. 31, 2025   121,476,215 1,000,000,000      
Balance at the beginning of the period at Mar. 31, 2025 1,129,047 $ 12 $ 0 1,294,745 (132,782) (32,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (233)       (233)  
Share-based compensation expense 1,873     1,873    
Other comprehensive income (loss) 48,376         48,376
Balance at the end of the period (in shares) at Jun. 30, 2025   121,476,215 1,000,000,000      
Balance at the end of the period at Jun. 30, 2025 $ 1,179,063 $ 12 $ 0 1,296,618 (133,015) 15,448
Balance at the beginning of the period (in shares) at Dec. 31, 2025 220,485,045 220,485,045 1,000,000      
Balance at the beginning of the period at Dec. 31, 2025 $ 2,179,916 $ 21 $ 0 2,362,943 (194,105) 11,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (41,549)       (41,549)  
Share-based compensation expense 8,728     8,728    
Restricted stock issuances and restricted stock unit vestings, net (in shares)   (113,718)        
Restricted stock issuances and restricted stock unit vestings, net (529)     (529)    
Issuance of common shares in conjunction with the Series A Preferred Stock Dividend (in shares)   668,347        
Other comprehensive income (loss) (12,707)         (12,707)
Balance at the end of the period (in shares) at Mar. 31, 2026   221,039,674 1,000,000      
Balance at the end of the period at Mar. 31, 2026 $ 2,133,859 $ 21 $ 0 2,371,142 (235,654) (1,650)
Balance at the beginning of the period (in shares) at Dec. 31, 2025 220,485,045 220,485,045 1,000,000      
Balance at the beginning of the period at Dec. 31, 2025 $ 2,179,916 $ 21 $ 0 2,362,943 (194,105) 11,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (54,891)          
Balance at the end of the period (in shares) at Jun. 30, 2026 218,987,253 218,987,253 1,000,000      
Balance at the end of the period at Jun. 30, 2026 $ 2,096,287 $ 21 $ 0 2,369,710 (248,996) (24,448)
Balance at the beginning of the period (in shares) at Mar. 31, 2026   221,039,674 1,000,000      
Balance at the beginning of the period at Mar. 31, 2026 2,133,859 $ 21 $ 0 2,371,142 (235,654) (1,650)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (13,342)       (13,342)  
Share-based compensation expense 10,778     10,778    
Restricted stock issuances and restricted stock unit vestings, net (in shares)   (459,229)        
Restricted stock issuances and restricted stock unit vestings, net (2,762)     (2,762)    
Issuance of common shares in conjunction with the employee stock purchase plan (in shares)   285,025        
Issuance of common shares in conjunction with the employee stock purchase plan 1,983     1,983    
Repurchases of common stock (in shares)   (1,878,217)        
Repurchases of common stock (15,684)     (15,684)    
Reclassification of liability-classified awards to equity-classified awards 4,253     4,253    
Other comprehensive income (loss) $ (22,798)         (22,798)
Balance at the end of the period (in shares) at Jun. 30, 2026 218,987,253 218,987,253 1,000,000      
Balance at the end of the period at Jun. 30, 2026 $ 2,096,287 $ 21 $ 0 $ 2,369,710 $ (248,996) $ (24,448)